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ARTICLE
Human GBP1 binds LPS to initiate assembly of a
caspase-4 activating platform on cytosolic bacteria
José Carlos Santos1,3, Dave Boucher 1,3, Larisa Kapinos Schneider2, Benjamin Demarco 1, Marisa Dilucca1,
Kateryna Shkarina 1, Rosalie Heilig1, Kaiwen W. Chen 1, Roderick Y. H. Lim 2 & Petr Broz 1✉
The human non-canonical inflammasome controls caspase-4 activation and gasdermin-D-
dependent pyroptosis in response to cytosolic bacterial lipopolysaccharide (LPS). Since LPS
binds and oligomerizes caspase-4, the pathway is thought to proceed without dedicated LPS
sensors or an activation platform. Here we report that interferon-induced guanylate-binding
proteins (GBPs) are required for non-canonical inflammasome activation by cytosolic Sal-
monella or upon cytosolic delivery of LPS. GBP1 associates with the surface of cytosolic
Salmonella seconds after bacterial escape from their vacuole, initiating the recruitment of
GBP2-4 to assemble a GBP coat. The GBP coat then promotes the recruitment of caspase-4
to the bacterial surface and caspase activation, in absence of bacteriolysis. Mechanistically,
GBP1 binds LPS with high affinity through electrostatic interactions. Our findings indicate that
in human epithelial cells GBP1 acts as a cytosolic LPS sensor and assembles a platform for
caspase-4 recruitment and activation at LPS-containing membranes as the first step of non-
canonical inflammasome signaling.
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D
etection of lipopolysaccharide (LPS) is central to host
defense against Gram-negative bacterial infections and to
the pathogenesis of sepsis. Extracellular LPS is sensed by
Toll-like receptor 4 (TLR4), which induces the production of
cytokines via the MyD88 and TRIF signaling pathways1. Cyto-
solic LPS, on the other hand, is detected by the so-called non-
canonical inflammasome, which controls the activation of cas-
pase-4/−5 in humans and caspase-11 in mice2–6. These caspases
cleave the pore-forming cell death effector gasdermin D
(GSDMD) to induce pyroptosis and cytokine release. While the
activation of other caspases requires their recruitment to multi-
protein platforms formed by dedicated sensor and adaptor pro-
teins (e.g., DISC, apoptosome and canonical inflammasome), no
comparable platform has yet been reported for caspase-4/−5 or
−11. Instead, their activation appears to involve a new mode of
pattern recognition in which caspase-4/−11 act both as sensor
and executor without the need for additional adaptor proteins or
co-factors5. This model was proposed based on the observation
that caspases-4/−11 binds the highly hydrophobic lipid A moiety
of LPS through their CARD (caspase recruitment domain),
resulting in their oligomerization and activation5. However, since
LPS is hydrophobic and normally present within bacterial
membranes, it is conceivable that cytosolic LPS sensing could
require accessory factors in analogy to LPS-binding protein (LBP)
or cluster of differentiation 14 (CD14) that are required for
TLR4 signaling. LBP binds to LPS-containing outer membrane of
bacteria and promotes the transfer of LPS onto CD14, which then
delivers LPS to the MD-2/TLR4 complex7,8.
Caspase-11 activation in mouse macrophages transfected with
LPS or infected with Gram-negative bacteria requires the
expression of interferon (IFN)-inducible GTPases, which include
the GBPs (guanylate-binding proteins) or IRGs (immunity-rela-
ted GTPases)9–12. These GTPases are highly upregulated after
type-I or type-II IFN priming, and essential for cell-autonomous
immunity against a variety of viruses, bacteria and parasites13. In
macrophages, several GBPs as well as Irgb10 were found to target
intracellular Gram-negative bacteria, such as Salmonella enterica
serovar Typhimurium (referred to as Salmonella), Francisella
novicida and Escherichia coli. Since this recruitment correlated
with bacterial lysis and the activation of caspase-11, it gave rise to
a model in which GBPs recruit Irgb10 towards bacterial mem-
branes, thereby unleashing an Irgb10-dependent membranolytic
activity that kills the pathogen and concomitantly liberates LPS
for the activation of non-canonical inflammasome11. However,
since humans lack the IRG family (except for a truncated IRGM
copy and IRGC), and GBPs are nevertheless required for LPS-
induced caspase-4 activation, the current model needs to be
confirmed in human cells14,15.
Here we report that IFNγ priming and the induction of GBPs
are necessary for caspase-4 activation in human epithelial cells
and monocytes/macrophages during infection with the Gram-
negative bacterium Salmonella or after cytosolic LPS delivery by
transfection or electroporation. We show that human GBP1
targets cytosolic Salmonella seconds after the bacteria escape from
the vacuole and enter into the cytosol, and that GBP1 initiates the
hierarchical recruitment of GBP2-4 and the assembly of a GBP
coat on cytosolic bacteria. This GBP coat does not induce bac-
teriolysis, but instead initiates the recruitment and activation of
caspase-4 to the surface of cytosolic bacteria. Human GBPs play
distinct functional roles in this process: GBP1 together with GBP4
recruit caspase-4, whereas GBP3 is mainly required for caspase-4
activation. Investigating the mechanism by which GBP1 recog-
nizes cytosol-exposed bacteria, we demonstrate that LPS associ-
ates with GBP1 in pyroptotic cells and that recombinant GBP1
binds LPS with high affinity. Monomeric GBP1 associates with
LPS micelles to form a high-molecular weight complex upon
incubation with LPS, and this association occurs via electrostatic
interactions involving negative charges on LPS. Consistently,
mutagenesis of GBP1 shows that positively charged residues are
necessary for LPS binding and recruitment to bacteria. In con-
clusion, we show that GBP1 acts as a bona-fide cytosolic LPS
sensor that detects and targets the LPS-containing membranes of
Gram-negative bacteria, where it assembles a platform that pro-
motes caspase-4 recruitment and activation.
Results
Salmonella-induced caspase-4 activation requires IFNγ prim-
ing. To study the human non-canonical inflammasome and its
modulation by priming, we infected naive or IFNγ-primed HeLa
cells, which lack canonical inflammasome pathways, with the
facultative intracellular bacterium Salmonella. Since HeLa cells
express TLR4 but not MD-2 and are thus not responsive to
extracellular bacterial LPS16, we primed the cells with IFNγ, a
cytokine that also plays a critical role in intestinal immunity
against Salmonella17. Salmonella replicated rapidly in naive HeLa
but was strongly restricted in IFNγ-primed cells (Fig. 1a), despite
similar levels of bacterial invasion (Supplementary Fig. 1a).
Strikingly, IFNγ-primed HeLa cells underwent lytic cell death
with typical features of pyroptosis, such as plasma membrane
swelling and ballooning, and nuclear condensation (Fig. 1b,
Supplementary Fig. 1b–e and Supplementary Movies 1, 2), and
released mature IL-18 (Supplementary Fig. 1f). Since in epithelial
cells a subset of Salmonella escape from the Salmonella-con-
taining vacuole (SCV) into the cytosol within the first hour after
entry18,19, we hypothesized that Salmonella could activate the
non-canonical inflammasome as previously observed in mouse
macrophages20. To test this, we infected naive or IFNγ-primed
wild-type, CASP4–/– and GSDMD–/– HeLa (Supplementary
Fig. 1g). Deletion of CASP4 or GSDMD did not alter bacterial
invasion, but abrogated Salmonella-induced IFNγ-dependent cell
death (Fig. 1c and Supplementary Fig. 1h–k), confirming that
Salmonella infection of HeLa cells activates the non-canonical
inflammasome in an IFNγ-dependent manner. While bacterial
replication was increased, IFNγ priming still partially reduced
intracellular bacterial replication in CASP4–/– and GSDMD–/–
HeLa (Supplementary Fig. 1l), suggesting that cell death was not
the only mechanism by which IFNγ restricts bacterial growth.
This finding was confirmed using Salmonella expressing PuhpT-
GFP, a reporter for cytosolic replication (e.g., GFP under the
control of the hexose phosphate transporter promoter, which
responds to exogenous glucose-6-phosphate21 found exclusively
in the host cytosol) (Supplementary Fig. 1m–o). Furthermore,
using a chloroquine (CHQ)-resistance assay, an antimicrobial
agent that only reaches bactericidal levels when concentrated
within endocytic compartments22,23, we found that IFNγ priming
mainly restricted cytosolic Salmonella (Supplementary Fig. 1p, q)
thus reducing hyper-replication of the cytosolic population of
Salmonella (Supplementary Fig. 1r, s)24,25. Thus, IFNγ controls a
major caspase-4- and GSDMD-dependent mechanism that
restricts cytosolic Salmonella replication by inducing host cell
pyroptosis, and a minor mechanism that acts independently of
cell death.
We next determined whether IFNγ was necessary to promote
access of Salmonella or their LPS to the cytosol by quantifying
bacterial resistance to CHQ at 1.5 h post-infection (p.i.). When
compared with naive cells, IFNγ priming did not induce
Salmonella escape to the host cytosol (Fig. 1d), indicating that
IFNγ controlled the detection of LPS after bacterial entry into the
cytosol. To confirm this, we next transfected cells with ultrapure
E. coli or Salmonella LPS. Similarly to Salmonella infection, LPS
transfection only caused cell death in IFNγ-primed HeLa and was
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completely abrogated by deletion of CASP4 or GSDMD (Fig. 1e
and Supplementary Fig. 2a). IFNγ-priming was also required
for pyroptosis and IL-18 release after LPS transfection (Fig. 1f
and Supplementary Fig. 2b–d) and after LPS electroporation
(Fig. 1g and Supplementary Fig. 2e) in a panel of human cell
lines and primary cells, including human small intestinal
epithelial cells (HIEC-6). To further substantiate that caspase-4
activation requires IFNγ, we transfected LPS into naive or IFNγ-
primed cells and pulled down active caspase-4 using a cell-
permeable pan-caspase activity probe, biotin-VAD(Ome)-fmk
(bVAD-fmk)26. Active caspase-4 was only pulled down when
cells where first primed with IFNγ and then transfected with LPS
(Supplementary Fig. 2f). In accordance, LPS transfection only
induced caspase-4 and GSDMD cleavage in IFNγ-primed cells
(Fig. 1h and Supplementary Fig. 2g). Importantly, IFNγ-priming
had no impact on the level of caspase-4 expression, since unlike
murine caspase-11, caspase-4 was not induced by IFNγ (Fig. 1h, i
and Supplementary Fig. 2c, g, h). To assess if IFNγ controlled
caspase-4 activation upstream or downstream of LPS binding, we
prepared lysates from HeLa or HBEC3-KT cells transfected with
biotinylated LPS and pulled down LPS-interacting proteins with
streptavidin-coupled beads. In both cell types caspase-4 could
only be pulled-down with LPS in IFNγ-primed but not in naive
cells (Fig. 1i and Supplementary Fig. 2h). Altogether, these
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Fig. 1 IFNγ priming is required for LPS-induced caspase-4 activation in human epithelial cells. a–c Intracellular bacterial fold-replication (a) and release
of LDH (b, c) in naive or IFNγ-primed wild-type, CASP4–/– or GSDMD–/– HeLa cells, at 1 or 6-h post-infection (p.i.) with Salmonella. Cells in 96-well plates
were infected for 30min, washed and gentamicin was added to kill extracellular bacteria. At the indicated time points supernatant was collected to
determine the release of LDH, and then cells were lysed and the number of viable intracellular bacteria was determined by counting colony forming units
(CFUs). The bacterial fold-replication was calculated relative to 1 h p.i. d Percentage of CHQ-resistant cytosolic Salmonella in naive or IFNγ-primed HeLa at
1.5 h p.i. Cells were infected for 30min as in (a) and then treated with gentamicin ± CHQ for an additional 1 h before cells were lysed and bacteria counted
by CFUs. The percentage of cytosolic bacteria was calculated as the ratio of (CHQ+ gentamicinresistant / gentamicinresistant). e–g Release of LDH from
naive or IFNγ-primed cells, 5 h after transfection with LPS (2.5 µg/50,000 cells) or 3–4 h after electroporation with LPS (300 ng/50,0000 cells).
hWestern blot analysis of full length (p43) and cleaved (p32) caspase-4 in the supernatants and cell lysates from naive or IFNγ-primed HaCaT cells, upon
transfection with E. coli LPS LPS (2.5 µg/50,000 cells). i Streptavidin pull-down assay of the binding of biotin-conjugated LPS to endogenous caspase-4
from the lysates of naive or IFNγ-primed HBEC3-KT. Cells in 6-well plates were transfected with LPS-biotin (10 µg) or left untransfected, and biotinylated
substrate was pulled down using equal amounts of streptavidin magnetic beads, which were then eluted in equal volumes of SDS-PAGE reducing sample
buffer. Streptavidin-bound and -unbound fractions were analyzed by immunoblotting for caspase-4. Graphs show the mean ± SD, and data are pooled from
two to six independent experiments performed in triplicate (a–g) or representative of two (h, i) independent experiments. *** P < 0.001; ns, not significant;
two-tailed t-test.
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findings suggest that in human epithelial cells one or several
IFNγ-induced proteins are required for LPS-induced caspase-4
activation.
GBP1 is required for non-canonical inflammasome activation.
Since caspase-11 activation in mouse macrophages requires IFN-
induced GTPases, we speculated that human GBPs were neces-
sary for LPS-induced caspase-4 activation. In agreement with
previous studies27, we found that GBPs expression in HeLa cells
was strongly upregulated by IFNγ priming (Supplementary
Fig. 3a). RNA interference-mediated silencing of GBPs expression
revealed a consistent reduction of LDH release in cells lacking
GBP1 both after Salmonella infection as well as LPS transfection
(Supplementary Fig. 3b–g). To confirm the phenotype, we gen-
erated GBP1–/– HeLa cells by CRISPR-Cas9 genome targeting
(Fig. 2a) and found that GBP1-deficiency completely abrogated
LDH release down to the background levels that were observed in
naive cells after Salmonella infection or LPS transfection (Fig. 2b,
c and Supplementary Fig. 3h, i), without altering bacterial entry
(Supplementary Fig. 3j–m). GBP1-deficient cells were also unable
to cleave and activate caspase-4 upon LPS transfection or Sal-
monella infection (Fig. 2d, e, p32 fragment). Furthermore, GBP1
was strongly required for LDH release when LPS was delivered by
electroporation (Fig. 2f). Similarly to the knockout of CASP4 or
GSDMD, GBP1-deficiency or knock-down of individual GBPs in
HeLa only resulted in a partial loss of IFNγ-dependent restriction
of cytosolic Salmonella replication (compare Supplementary
Figs. 1l-s and 3n-p). Finally, GBP1 knock-down in HBEC3-KT
and HaCaT cells also reduced LDH release upon LPS transfection
(Fig. 2g and Supplementary Fig. 3q), demonstrating that GBP1 is
important to regulate LPS-induced cell death in several human
epithelial cell lines.
GBP1 targets intracellular Salmonella to recruit GBP2-4.
Having demonstrated a role for GBPs in caspase-4 activation, we
next expressed fluorescently tagged GBPs individually in naive or
primed cells to determine if they target intracellular Salmonella.
We found that in IFNγ-primed HeLa, GBP1, −2, −3 and −4
coated around 20–30% of intracellular Salmonella at 1 h p.i.,
whereas only very few bacteria were positive for GBP5, −6 or −7
(Fig. 3a, b and Supplementary Fig. 4a). Recruitment of tagged
GBP2, −3 and −4 was strongly dependent on IFNγ priming,
since these GBPs only poorly associated with Salmonella when
expressed in naive cells. By contrast, eGFP-GBP1 associated with
Salmonella even when expressed in naive cells, albeit at lower
levels than in primed cells.
GBPs are known to homo- and hetero-oligomerize, forming a
coat when recruited to intracellular pathogens28. We hypothe-
sized that GBP1 had the ability to target Salmonella indepen-
dently of other GBPs, whereas GBP2-4 required GBP1 for
recruitment27. Indeed, recruitment of GBP2, −3 and −4 to
Salmonella was completely abrogated in IFNγ-primed GBP1–/–
HeLa cells (Fig. 3c). Furthermore, GBP1 co-expression in naive
cells was sufficient to induce recruitment of tagged GBP2-4 to
f g
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intracellular Salmonella (Supplementary Fig. 4b, c) to levels
similar to those observed in IFNγ-primed cells (Fig. 3b). GBP1
targeting of intracellular Salmonella was also observed in primary
human small intestinal epithelial cells (Supplementary Fig. 4d).
Finally, time-lapse confocal microscopy of infected cells co-
expressing GBP1 and either GBP2, −3 or −4, revealed that GBP1
and GBP2 were recruited simultaneously to the bacteria
(Supplementary Fig. 4e and Supplementary Movie 3), whereas
GBP3 and GBP4 were only recruited to bacteria minutes after
GBP1 recruitment (Supplementary Fig. 4f, g and Supplementary
Movies 4, 5). These data show that GBP1 is the first to target
intracellular Salmonella and orchestrates the hierarchical recruit-
ment of additional human GBP family members, namely GBP2-4.
To gain further mechanistic insights on how GBP1 accumulates
on intracellular Salmonella we analyzed different GBP1 mutants
(Fig. 3d and Supplementary Fig. 5a, b)29. GTP hydrolysis, a triple-
arginine polybasic motif (584-586) and the C-terminal CaaX box-
dependent farnesylation were all required for proper GBP1
recruitment/accumulation around intracellular Salmonella (Fig. 3e
and Supplementary Fig. 5c). Interestingly, HA-GBP1ΔCaaX was
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still not recruited to Salmonella even when co-expressed with
mCherry-GBP1wt (Fig. 3f), suggesting that GBP1 oligomers
around bacteria are only formed if monomers are farnesylated
and capable of properly inserting into membranes.
GBPs target cytosolic Salmonella seconds after SCV rupture.
Since mouse GBPs were previously associated with vacuolar
rupture10, we next asked if human GBPs associate with the SCV
or cytosolic Salmonella by using galectin-3, a protein that binds to
β-galactosides found on the inner leaflet of vacuolar membranes,
as a marker for ruptured vacuoles30. GBP1-4 were indeed only
found in the vicinity of galectin-3-positive bacteria (Fig. 4a), but
closer analysis revealed that GBPs targeted the cytosol-exposed
part of the bacteria and not the galectin-3-positive ruptured
vacuoles (Fig. 4a, insets). Consistently, GBPs did not co-localize
with LAMP1 (Supplementary Fig. 6a), a known marker of SCV
membranes31. Furthermore, we did not observe a reduction in the
percentage of cytosolic (Fig. 4b) or galectin-3-positive Salmonella
(Supplementary Fig. 6b) in GBP1–/– cells, indicating that human
GBP1-4 did not promote the escape of Salmonella from the SCV
in HeLa cells, but associate with bacteria upon cytosolic entry.
GBP1 also associated with Shigella flexneri after its escape from
the endocytic vacuole but not with cytosolic Listeria mono-
cytogenes (Supplementary Fig. 6c)27,29.
We next used time-lapse confocal microscopy to follow the
kinetics of SCV membrane rupture, GBP recruitment and
pyroptosis. In Salmonella-infected cells, SCV rupture and
galectin-3 recruitment was followed by a rapid and massive
recruitment of GBP1, often occurring less than 30 seconds upon
detectable galectin-3 appearance (Supplementary Fig. 6d and
Supplementary Movie 6). GBP1 recruitment often started at one
region of the bacterium, presumably the part exposed to the
cytosol, then formed a coat around bacteria. GBP1 recruitment to
cytosolic Salmonella was followed by pyroptotic cell death
(Supplementary Fig. 6e and Supplementary Movie 7), and
consistently, the majority of pyroptotic cells featured GBP1-
positive Salmonella (Supplementary Fig. 6f).
In mouse macrophages, GBP targeting of bacteria mediates
recruitment of Irgb10, which correlates with the lysis of targeted
bacteria and caspase-11 activation11. To determine if human
GBPs lysed cytosolic Salmonella in HeLa cells, as a mechanism for
LPS release and caspase-4 activation, we monitored GBP
recruitment in GSDMD–/– cells infected with Salmonella-dsRed.
Live-cell imaging revealed that while the bacteria were rapidly
targeted by GBP1, they continued to divide in the host cell
cytosol, showing no signs of lysis or viability loss (Supplementary
Fig. 7a–d and Supplementary Movies 8–11). Therefore, GBP1
targets the surface of Salmonella within seconds upon rupture of
the SCV membrane and bacterial escape to the host cytosol, and
is followed by rapid induction of caspase-4-dependent pyroptosis
independently of bacteriolysis.
GBPs control caspase-4 recruitment to cytosolic Salmonella.
Since GBP recruitment did not lyse bacteria, we presumed that
GBPs control LPS-dependent caspase-4 activation by another
mechanism. When probing for the intracellular localization of
caspase-4 we found that caspase-4-eGFP was recruited on Sal-
monella, often covering the entire bacterium (Fig. 4c). Caspase-4
recruitment onto Salmonella absolutely required IFNγ priming as
it was not detectable in naive cells (Fig. 4c, d and Supplementary
Fig. 8a) despite high expression levels of the caspase. Time-lapse
confocal microscopy of caspase-4-eGFP-expressing IFNγ-primed
HeLa infected with Salmonella-dsRed showed that caspase-4,
although initially diffused in the cytosol, was recruited to
intracellular Salmonella within minutes, and that caspase-4
recruitment to Salmonella was rapidly followed by pyroptotic
cell death in the majority of cells (Supplementary Fig. 8b, c and
Supplementary Movie 12). Consistently, the few cells that did not
recruit caspase-4 to bacteria did not initiate pyroptosis (Supple-
mentary Fig. 8d and Supplementary Movie 13).
Recruitment of caspase-4 to Salmonella correlated with SCV
lysis because caspase-4-positive bacteria were found in the
vicinity of galectin-3-positive ruptured vacuoles (Fig. 4e and
Supplementary Fig. 8e). Similarly to GBP1-4, caspase-4 did not
co-localize with LAMP1-positive SCVs (Supplementary Fig. 8f),
but targeted the cytosol-exposed part of the bacterium and not
the lysed vacuole (Fig. 4e, arrows and arrowheads, and
Supplementary Fig. 8e, inset images). Super-resolution micro-
scopy further confirmed that caspase-4 accumulated on the
bacterial surface but not on ruptured SCVs (Fig. 4f and
Supplementary Fig. 8g). Finally, time-lapse confocal microscopy
of infected cells showed that caspase-4 was recruited to
Salmonella 5–10 min after the first appearance of a galectin-3
signal (Fig. 4g, h and Supplementary Movie 14), altogether
demonstrating that caspase-4 targets cytosolic Salmonella after
SCV rupture.
Since GBP1 also targeted cytosolic Salmonella and was
required for caspase-4 activation, we hypothesized that GBPs
might either control the recruitment of caspase-4 to cytosolic
bacteria and/or the activation of caspase-4 at the bacterial surface.
Time-lapse microscopy of HeLa cells co-expressing mCherry-
GBP1 and caspase-4-eGFP showed that GBP1 recruitment
preceded caspase-4 recruitment to the same bacterium by several
minutes, and this was followed by pyroptosis (Fig. 4i and
Supplementary Movie 15). This is consistent with the faster
recruitment of GBP1 upon SCV rupture compared with the
slower recruitment of caspase-4 (Supplementary Fig. 6d and
Fig. 4g, h). Remarkably, we also observed a complete reduction in
caspase-4 recruitment to Salmonella in GBP1–/– HeLa (Fig. 4j),
while GBP1 was still recruited to bacteria in CASP4–/– cells
(Supplementary Fig. 9). Together with the observation that GBP1-
deficient cells were not able to activate caspase-4 (Fig. 2), the data
suggest that GBP1, either directly or by controlling GBP2-4
recruitment, initiates the recruitment of caspase-4 to the bacterial
surface.
GBP1/3/4 are sufficient for LPS-induced caspase-4 activation.
We next addressed the individual functions of GBP1-4 in
caspase-4 recruitment and activation. GBP1–/– HeLa neither
recruit GBP2-4 nor caspase-4 to cytosolic bacteria (Figs. 3c and
4j), thus making it impossible to determine whether GBP1 con-
trols caspase recruitment directly or via other GBPs. We therefore
co-expressed caspase-4-eGFP and mCherry-GBP1 in naive or
IFNγ-primed cells, and determined caspase targeting to cytosolic
Salmonella. While GBP1 targeted cytosolic Salmonella regardless
of IFNγ priming, caspase-4 was only recruited to bacteria in
primed cells (Fig. 5a). Thus, other GBPs and/or an unknown
IFNγ-induced factor are necessary for GBP1-dependent caspase-4
recruitment. We thus co-expressed caspase-4 and mCherry-GBP1
with either doxycycline (Dox)-inducible eGFP-tagged GBP2,
GBP3 or GBP4 in naive HeLa cells and visualized
caspase recruitment by confocal microscopy (Supplementary
Fig. 10a and Fig. 5b). GBP1 alone, or GBP1 together with GBP2
did not restore caspase-4 recruitment to cytosolic Salmonella in
naive cells. On the other hand, co-expression of GBP1 with
GBP4 and to a lesser degree with GBP3 was sufficient to
induce recruitment of caspase-4 to cytosolic bacteria (Fig. 5b, c).
The same was observed when using different vectors to co-
express the proteins (Supplementary Fig. 10b), which excluded
vector-biased caspase-4 recruitment and indicated that GBP1
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controls recruitment of caspase-4 mainly via GBP4 and partially
via GBP3.
We next asked if expression of single or multiple GBPs in naive
cells also restores caspase-4-dependent pyroptosis. Individual
expression of GBP1-7 was not sufficient to induce LPS-induced
pyroptosis in naive cells (Supplementary Fig. 10c, d). By contrast,
LPS transfection induced significantly elevated levels of LDH
release in naive cells co-expressing either GBP1/3/4 or GBP1/2/3/
4 (Fig. 5d and Supplementary Fig. 10e, f). Interestingly, co-
expression of only GBP1/3 already restored some LPS
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transfection-induced pyroptosis, whereas co-expression of GBP1/
4 had no effect even though it was sufficient to promote caspase-4
recruitment on Salmonella (Fig. 5b, c and Supplementary
Fig. 10b). Thus, while GBP1 drives caspase-4 recruitment to
cytosolic Salmonella mainly by GBP4, GBP3 is nevertheless
necessary to yield caspase-4 activation (Fig. 5b, d). In conclusion,
these experiments indicate that a complex formed by GBP1, −3
and −4 promotes caspase-4 recruitment and activation following
LPS detection without the requirement for other IFNγ-
induced genes.
GBP1 directly binds LPS. Since GBPs showed a recruitment to
cytosolic Gram-negative bacteria, OMVs or even transfected LPS
(Fig. 3, Supplementary Fig. 6c and ref. 12), we tested if GBPs can
directly bind LPS. Similarly to caspase-4 (Fig. 1i and Supple-
mentary Fig. 2g), biotin-LPS was able to pull-down eGFP-GBP1
and to a lesser degree eGFP-GBP3, but not tagged GBP2 or GBP4
(Fig. 6a) from HeLa lysates. To assess if this interaction was
direct, we next purified LPS-free recombinant His-GBP1 from
CleanColi® BL21 (DE3) bacteria that produce Lipid IVA (which
does not activate caspase-4/−11) instead of LPS followed by a
lipid removal protocol32 and tested GBP1-LPS binding by surface
plasmon resonance (SPR). SPR showed a direct binding of LPS to
immobilized GBP1 with a KD of ~60 nM, which is comparable to
the published KD of the LPS-caspase-4 and LPS-caspase-11
interaction (Fig. 6b–d). Kinetic analysis also showed that GBP1-
LPS binding best fitted with a two-state-reaction model that
describes a situation where initial binding is followed by a con-
formational change that stabilizes the complex. The com-
plementary experiment with immobilized LPS also yielded similar
a KD (Supplementary Fig. 11a, b), however the response was
relatively weak since only a small amount of LPS absorbed on the
chip surface. Moreover, microscale thermophoresis (MST) of
GBP1 and FITC-LPS confirmed the interaction yielding a com-
parable KD value (Supplementary Fig. 11c).
We next investigated the consequences of the LPS-GBP1
interaction, since LPS was suggested to induce caspase-11/−4
oligomerization5. LPS-free recombinant GBP1 ran as a single
monomeric peak on size-exclusion chromatography (SEC), close
to its predicted size of 68.5 kDa (Fig. 6e, f, Supplementary Fig. 11d
and Table 1), while E. coli and Salmonella Typhimurium LPS
formed micelles eluting at around 1000 kDa (void volume). When
GBP1 was incubated with LPS, the elution profile changed,
resulting in a shift of the majority of GBP1 to higher molecular
weight peaks from the range of 400 kDa to over 1000 kDa (Fig. 6e,
f, Supplementary Fig. 11d and Table 1). The most prominent
peak was found to be at 1000 kDa, indicating that GBP1 bound to
LPS micelles, but smaller complexes were detected as well.
Interestingly, even LPS from Rhodobacter sphaeroides induced a
shift of GBP1 to higher molecular weight peaks (Supplementary
Fig. 11d, e), despite acting as an antagonist of caspase-11 and not
being able to induce oligomerization of the caspase5. Conversely,
incubation of GBP1 with lipoteichoic acid (LTA) or peptidogly-
can (Supplementary Fig. 11f, g) did not result in a similar shift.
LBP and ovalbumin were used as positive and negative LPS-
binding controls, respectively (Supplementary Fig. 12a)33. We
next tested what part of LPS is required for the binding of GBP1
to LPS micelles. LPS from E. coli Ra, Rc, Rd, Re mutant strains,
which lack the O-antigen and outer core, respectively, was still
bound by GBP1 as it resulted in a shift to high-molecular weight
peaks (Supplementary Fig. 12b, c). Consistently, Salmonella
ΔwaaL or ΔwaaG mutants (lacking the O-antigen or outer core,
respectively) still recruited GBP1 and caspase-4 in infected cells
(Supplementary Fig. 12d–f). Since the LPS-GBP1 interaction was
highly sensitive to detergents, the binding to Lipid A could not be
tested since this requires solubilization of Lipid A with Tween-20
or other detergents5. Since GBP1 displays an oligomerization-
dependent activation of GTP hydrolysis34, we finally assessed the
impact of LPS on GBP1 GTPase activity (Fig. 6g). As reported
previously, GBP1 had some intrinsic ability to hydrolyze GTP on
its own, but its GTPase activity was significantly increased when
incubated with LPS, supporting the fact that GBP1 interacts with
LPS, and suggesting that LPS binding might promote an
oligomeric state. In conclusion these findings indicated that
GBP1 was able to bind directly to LPS, and that the LPS Lipid A
and inner core region were sufficient for LPS-GBP1 interaction.
GBP1-LPS interaction involves electrostatic interactions. Each
LPS molecule from E. coli has 6–8 negatively charged groups,
from phosphates and acid groups in the Lipid A and inner core
(Supplementary Fig. 12b)35. Given that human GBP1 lacks the
hydrophobic pockets that comprise the LPS binding sites in CD14
and MD-2, we hypothesized that GBP1 binds to LPS by elec-
trostatic interactions, similarly to LBP36,37. Consistently, GBP1
binding to LPS micelles was disrupted by incubation with cations
(Ca2+), which neutralize the negative charges on LPS35,38, or by
incubation with polymyxin B, which interacts with the LPS Lipid
A and inner core region through ionic and hydrophobic forces,
resulting in more monomeric GBP1 and reduced levels of GBP1-
LPS association (Fig. 7a and Supplementary Fig. 13). Further-
more, dephosphorylating LPS with alkaline phosphatase
reduced GBP1-LPS binding and cell death upon LPS transfection
Fig. 4 GBP1 targets cytosolic Salmonella and is required for caspase-4 recruitment to the bacterial surface. a Fluorescence confocal microscopy of IFNγ-
primed wild-type HeLa co-expressing galectin-3-eGFP (green) and mCherry-GBP1-7 (red) and infected with Salmonella for 1 h. b Percentage of CHQ-
resistant cytosolic Salmonella in naive or IFNγ-primed wild-type or GBP1–/– HeLa at 1.5 h p.i. Cells in triplicate wells were infected for 30min and then
treated with gentamicin ± CHQ for an additional 1 h before lysing the cells and determining CFUs. The percentage of cytosolic bacteria was calculated as
the ratio of (CHQ+ gentamicinresistant/gentamicinresistant). c Fluorescence confocal microscopy of naive or IFNγ-primed HeLa expressing caspase-4-eGFP
(green) and infected with Salmonella-dsRed for 1 h. d. Percentage of caspase-4-eGFP positive Salmonella at 1 h p.i., quantified by counting 100–200 bacteria
per coverslip. nd, not detected. e, f Fluorescence confocal microscopy of IFNγ-primed HeLa co-expressing galectin-3-mOrange (red) and caspase-4-eGFP
(green) and infected with Salmonella for 1 h. g Time-lapse fluorescence confocal microscopy of IFNγ-primed HeLa expressing caspase-4-eGFP (green) and
galectin-3-mOrange (red) and infected with Salmonella. h. Mean normalized fluorescence intensities of galectin-3-mOrange and caspase-4-eGFP over time.
Fluorescence intensities were quantified in a region of interest as exemplified in the figure, containing an event of caspase-4 and galectin-3 recruitment to
an individual bacterium. The relative intensity signals were aligned using the time point of onset of galectin-3 recruitment as zero and the mean and SD of
six different events were plotted. i Time-lapse fluorescence confocal microscopy of IFNγ-primed HeLa co-expressing caspase-4-eGFP (green) and
mCherry-GBP1 (red) and infected with Salmonella. Images were acquired every 60 s. DIC, differential interference contrast. j Percentage of caspase-4-eGFP
positive Salmonella at 1 h p.i., in IFNγ-primed wild-type and GBP1–/– HeLa. 100–200 bacteria were counted per coverslip. Representative confocal images are
shown and scale bars correspond to 1 µm (f), 5 µm (c, e, g) or 10 µm (a, i). Graphs show the mean ± SD, and data are pooled from two (b) or three (d, j)
independent experiments performed in triplicate or representative from at least three independent experiments (a, c, e–i). ***P < 0.001; ns, not significant,
two-tailed t-test.
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(Fig. 7a, b and Supplementary Fig. 13), indicating that the
phosphate groups found on Lipid A and inner core sugars of LPS
(Supplementary Fig. 12b) play an essential role in promoting
GBP1-LPS interaction and subsequent activation of the
non-canonical inflammasome pathway. Basic residues in the N-
terminal domain of LBP mediate binding to LPS micelles39. We
thus mutated several positively charged surface patches in GBP1
and tested the impact of the mutations on GBP1-LPS interaction
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Fig. 5 GBP1/4 are sufficient to recruit caspase-4 to Salmonella and together with GBP3 activate the non-canonical inflammasome in naive human
epithelial cells. a Fluorescence confocal microscopy of naive and IFNγ-primed HeLa co-expressing caspase-4-eGFP (green) and mCherry-GBP1 (red) and
infected with Salmonella for 1 h. DNA was stained with Hoechst (blue). Representative confocal images are shown and scale bar corresponds to 5 µm.
b Fluorescence confocal microscopy of IFNγ-primed or naive HeLa cells co-expressing mCherry-GBP1 (red), Dox-inducible eGFP-GBP1, −2, −3 or −4
(green) and caspase-4-V5 (gray), and infected with Salmonella for 1 h. DNA was stained with Hoechst (blue). eGFP-GBPs were expressed by inducing cells
with 1 µg/mL Dox for 16 h. Caspase-4-V5 was visualized by immunostaining with an anti-V5 antibody. Representative confocal images are shown and scale
bar corresponds to 10 µm. c Percentage of caspase-4-V5 positive Salmonella at 1 h p.i., quantified out of the mCherry-GBP1-positive bacteria. At least 50
GBP1-positive bacteria were counted per coverslip. d Percentage of cell death in HeLa cells co-expressing constitutive mCherry-GBP1 and Dox-inducible
eGFP or eGFP-GBP1, −2, −3 or −4. FLAG-GBP3 and HA-GBP4 were constitutively expressed together using a bicistronic plasmid. Cells were transfected
with the indicated plasmids for 24 h. eGFP-GBPs were induced for 16 h with 1 µg/mL Dox, whereas eGFP was induced for 3 h. Cells were then transfected
with E. coli-derived LPS (2.5 µg/50,000 cells) for 6 h and cell death values were normalized considering IFNγ-primed HeLa as 100% and naive cells co-
expressing mCherry-GBP1 and eGFP as 0%. Graphs show the mean ± SD, and data are pooled from two independent experiments performed in duplicate
(c), pooled from three independent experiments performed in triplicate (d) or are representative from two (b) or three (a) independent experiments. **P <
0.01; ***P < 0.001; one-way ANOVA.
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by SEC (Fig. 7c, d). While most mutations resulted in no or
minor effect on the binding of GBP1 to LPS micelles, mutation of
the triple-lysines 61-63 to alanines (A patch) notably reduced the
formation of the higher molecular weight GBP1 peaks (~40%)
and increasing the levels of monomeric GBP1, thus
suggesting that these residues are required for binding (Fig. 7d
and Supplementary Fig. 14a). Furthermore, expression of
GBP1KKK61-63AAA (A patch) resulted in a significant reduction of
targeting to cytosolic Salmonella compared with either GBP1WT
or GBP1KK87-88AA (B patch) (Fig. 7e, f and Supplementary
Fig. 14b). In summary, the results demonstrate that the GBP1-
LPS interaction involves electrostatic forces and that disrupting
the binding by dephosphorylating LPS or mutating GBP1 results
in reduced caspase-4-induced pyroptosis upon LPS transfection
or impaired GBP1 targeting of the bacterial surface.
Discussion
Here we report that GBP1 functions as an LPS sensor that
recognizes Gram-negative bacteria in the cytosol of human epi-
thelial cells, and that GBP1-LPS interaction involves electrostatic
forces (Supplementary Fig. 15). Given that GBP1 is necessary for
LPS-induced caspase-4 activation in various human cell types and
after various LPS delivery methods (electroporation, chemical
transfection, Gram-negative bacteria infection), our data imply
that GBP1 is the very first protein in the non-canonical
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Fig. 6 LPS binds to GBP1 to induce formation of a high-molecular weight protein complex. a Streptavidin pull-down assay for eGFP-GBP1-4 using biotin
or biotin-conjugated LPS. HeLa cells stably expressing Dox-inducible eGFP-GBP1, −2, −3, or −4 were primed with IFNγ and 1 µg/mL Dox was added for 16
h. 1 million cells were lysed and incubated with 2 µg LPS-biotin or biotin, and the biotinylated substrates were pulled down using equal amounts of
streptavidin magnetic beads, which were then eluted in equal volumes of SDS-PAGE reducing sample buffer. Streptavidin-bound and -unbound fractions
were analyzed by western blot using an antibody against GFP. b SPR sensorgram of E. coli LPS (O111:B4) binding to human GBP1 immobilized on a CM5 chip
surface. Sensorgram was obtained by using different LPS concentrations (47, 94, 188, 375, 750, and 1500 nM). Gray lines correspond to SPR data and
orange lines to model fits using a two-state-reaction model. c Saturation curve of the titration of LPS on GBP1 immobilized on a CM5 chip. d Calculated
dissociation constants (KD) for LPS binding to immobilized GBP1 (GBP1
im) or GBP1 binding to immobilized E. coli LPS (LPSim). Dissociation constants for
LPS-caspase-4 and LPS-caspase-11 were previously published by Shi et al.5. e, f Size exclusion chromatograms of recombinant, LPS-free His-tagged GBP1
incubated with various LPS derivatives. Following purification, GBP1 (1 µM) was incubated on ice with LPS (2 µM) for 5 h before being subjected to size-
exclusion analysis on a Superdex 200 10/30 GL column. Protein size was estimated using molecular weight standards. Curves were corrected by
subtracting LPS-specific absorbance at 280 nm. Individual fractions were run on a 12% acrylamide gel and immunoblotted against His6 to confirm the
presence of GBP1 in elution peaks (f). g GTPase activity analysis of recombinant GBP1. GBP1 (500 nM) was incubated with GTP (5 µM) with or without
ultrapure LPS (5 µM) for 30min before the reaction was stopped. Luminescence was normalized to a buffer-only control. Graphs show the mean ± SD, and
data are representative from three (a–d, g) or five (e, f) independent experiments performed with at least three independently expressed and purified
batches of recombinant His-GBP1.
Table 1 Observed molecular weights of GBP1 peaks after
incubation with various LPS.
Sample Theoretical size (kDa) Observed size (kDa)
GBP1 67.01 78.7
GBP1+ LPS-E. coli 1028; 401.8; 78.7
GBP1+ LPS-Salmonella 1140.5, 78.7
GBP1+ LPS-R. sph 1318.6; 364
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inflammasome pathway that interacts with LPS. This places GBP1
upstream of caspase-4 in cytosolic LPS sensing, raising the
question if it might act similarly to LBP which acts as a co-factor
for extracellular LPS detection by CD14 and MD-2/TLR4. Indeed,
the finding that GBP1-LPS requires negative charges on LPS
Lipid A and the inner core sugars as well as a positively charged
surface patch in GBP1 is reminiscent of the mode of LPS binding
by LBP, which involves two positively charged patches at the tip
of the LBP N-terminal domain. From a functional point of view
LBP and GBP1 will most likely differ. LBP binds to LPS micelles
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Fig. 7 GBP1 is recruited to the bacterial surface and binds LPS through electrostatic interactions. a Size exclusion chromatograms of recombinant His-
tagged GBP1 incubated with E. coli LPS, or with E. coli LPS pre-treated with CaCl2 (5mM), Polymyxin B (10 µg/mL) or with alkaline phosphatase. Curves were
corrected by subtracting the respective LPS-specific absorbance at 280 nm. Black curves representing control condition were overlayed. b Release of LDH from
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and to CD14 protein, and catalyzes multiple rounds of LPS
transfer to CD14, which will then transfer a single bound LPS
molecule to MD-2/TLR4. GBP1 on the other hand, does not
function alone, but as part of a GBP1-4 complex that assembles
on LPS-containing membranes. It is possible that this complex
recruits caspase-4 and then transfers LPS onto caspase-4 thus
promoting its activation. Alternatively, it is also possible that the
assembly of the GBP complex and insertion of the GBPs into the
bacterial membranes via lipid anchors results in a partial weak-
ening of membrane integrity, thus allowing caspase-4 to bind the
Lipid A moiety of LPS. Additional studies aimed at determining
the structure and composition of the GBP complex will be
necessary to understand how it promotes caspase-4 recruitment
and activation.
While it is not yet clear if the GBP1-LPS interaction also
requires structural determinants in LPS, the ability of GBP1 to
recognize negatively charged pathogen-derived molecules might
extend its function beyond the recognition of Gram-negative
bacteria. Indeed, GBP1 is known to be recruited to both the
surface of cytosolic parasites, such as T. gondii, as well as to the
membrane of the T. gondii parasitophorous vacuole, and to
assemble a GBP coat in a similar manner25,28. Interestingly, in
this case the GBP coat does not result in recruitment of caspase-4
(in line with the fact that parasites do not feature LPS), but in the
induction of caspase-8-dependent apoptosis40. It is thus likely
that parasites or their vacuoles feature molecules with similar
chemical properties as the LPS Lipid A and core polysaccharides
in their cell membrane or the membrane of the parasitophorous
vacuole. Identification of additional ligands that bind GBP1 or
other GBP family member will enhance our understanding of
host innate immunity and establish new paradigms for pattern
recognition.
The human-specific mechanism reported here is in contrast to
previous models that proposed that, in mice, GBPs promote non-
canonical inflammasome activation by facilitating vacuolar escape
and inducing bacterial membrane destruction10,41. While it is
unlikely that mouse GBPs function fundamentally differently
from human GBPs in the mechanism by which they recognize
pathogens, it is possible that the existence of IRGs in mouse
enhances their downstream effector functions. The lysis of bac-
teria and vacuoles reported in mouse cells (but not detected in
human cells), is most likely a consequence of GBP-mediated
recruitment of IRGs, such as Irgb10 that is reported to have
antimicrobial properties11. Thus, in addition to recruiting
caspase-11 directly in analogy to human GBPs, mouse GBPs
might also mediate access to LPS and LPS liberation through the
membranolytic activity of IRGs.
To our knowledge, our study is the first to report a ligand of
GBP1 and to characterize the mode of this interaction. While our
findings still need to be validated in primary human cells, it
nevertheless provides the first evidence that GBP1 and possibly
other GBPs function as direct innate immune receptors for
pathogen-associated molecular patterns, expanding the ever-
increasing repertoire of cytosolic innate immune defense
pathways.
Methods
Bacterial strains and mammalian cell culture. All bacteria were grown at 37 °C in
an orbital shaker. Salmonella enterica serovar Typhimurium strain SL1344 was
grown in lysogeny broth (LB) medium supplemented with 10 g/L NaCl and
streptomycin (50 µg/mL). Salmonella expressing dsRed (Salmonella-dsRed) was
grown by supplementing LB medium with ampicillin (50 µg/mL). Salmonella
enterica serovar Typhimurium strain 4/74 and their isogenic ΔwaaG or ΔwaaL
mutants were a kind gift from Jay Hinton (University of Liverpool, Liverpool).
Shigella flexneri M90T expressing the adhesin AfaI was a kind gift from Jost
Enninga (Institut Pasteur, Paris) and was grown in tryptic soy broth (TSB) sup-
plemented with ampicillin (50 µg/mL). Listeria monocytogenes strain EGD was a
kind gift from Pascale Cossart (Institut Pasteur, Paris) and was grown in brain-
heart infusion (BHI) medium. Unless stated otherwise, the HeLa clone CCL-2 from
ATCC was used. Human epithelial HT-29 and HeLa (CCL-2 or Kyoto clones) cells
were cultured in DMEM (Gibco) supplemented with 10% Fetal Calf Serum (FCS).
Caco-2/TC-7 were cultured in DMEM supplemented with 20% FCS. HT-29 and
Caco-2 cells were a kind gift from Shaynoor Dramsi (Institut Pasteur, Paris). THP-
1 and U937 cells were cultured in RPMI supplemented with 10% FCS. HBEC3-KT
cells were obtained from ATCC and were grown in Bronchial/Tracheal Epithelial
Cell Growth Medium (Cell Applications, Inc.). HaCaT cells were obtained from
CLS Cell Lines Service GmbH, and were grown in DMEM supplemented 10% FCS.
HIEC-6 cells were obtained from ATCC and grown in Opti-MEM (Gibco) sup-
plemented with 4% FCS, 10 mM Glutamine and 10 ng/mL of epidermal growth
factor (EGF). Human primary monocyte-derived macrophages (hMDMs) were
purified from buffy-coat obtained from the Swiss Red-Cross and purified and
cultured as described previously42. All cells were grown at 37 °C, 5% CO2.
Generation of CRISPR/Cas9 knockout cell lines. Knock-out HeLa cells lines
were generated using the Alt-R CRISPR-Cas9 System (Integrated DNA Technol-
ogies, IDT), by using a mix of a sequence-specific CRISPR RNA (crRNA), a
conserved, transactivating crRNA (tracrRNA) and recombinant Alt-R S. pyogenes
Cas9 (IDT). crRNA and tracrRNA were mixed to 1 µM, heated 5 min at 95 °C and
cooled to room temperature. 1 µM Alt-R Cas9 was mixed and incubated at room
temperature for 5 min. Lipofectamine RNAiMax transfection reagent (Invitrogen)
was then added and the mixture was incubated for 20 min at room temperature.
40,000 cells/well were reversely transfected with the previous mixture in 96-well
plates, to achieve a concentration of 10 nM ribonucleoprotein complex. After
incubation for 2 days at 37 °C, 5% CO2, single clones were generated by serial
dilutions and the desired gene knockouts were screened by performing the T7
endonuclease I assay, verified by sequencing of the PCR fragments and confirmed
by western blotting. The following crRNAs were used: AGGGATTCCAACAC
CTTAAG (for CASP4), CCACGTACACGTTGTCCCCG (for GSDMD) and
GAACACTAATGGGCGACTGA (for GBP1).
Plasmids, siRNAs, and cell transfection. Plasmids expressing N-terminal fluor-
escently tagged GBPs were generated by inserting the GBPs coding sequences at the
XhoI/HindIII sites of pEGFP-C1 and pmCherry-C1 (Clontech). pmiRFP703-GBP1
was generated by using the pEGFP-C1 plasmid and replacing eGFP by miRFP703
(addgene 8000143 was used as PCR amplification template) at the NheI/BglII sites,
and then inserting the GBP1 coding sequence at the XhoI/HindIII sites. Caspase-4-
eGFP was generated by fusing the amplified PCR products of caspase-4 and eGFP
and inserting the coding sequence into the NheI/HindIII sites of pEGFP-C1. The
pAIP vectors expressing HA-GBP1 or HA-GBP2 were a kind gift from T. Henry
(CIRI, Lyon) and were used to generate HA-tagged GBPs, by replacing GBP1 by
the GBP3 or −4 coding sequences at the EcoRI sites. The bicistronic plasmids
encoding FLAG-GBP3+HA-GBP4 were generated by inserting GBP3 or GBP4 at
the NotI/PmeI sites of the pBud-EGFP vector (addgene 23027)44. Doxycycline-
inducible eGFP-GBP1, −2, −3, −4 were generated by amplifying eGFP-GBPs
generated above by PCR and inserting the coding sequences at the BamHI site of
the pLVX-Puro vector (Clontech). All cloning was performed using In-Fusion
cloning technology (Clontech) and plasmids were verified by sequencing. Plasmids
encoding eGFP or mOrange tagged galectin-3 were a kind gift from Jost
Enninga30,45. HeLa cells were either plated onto 8-well µ-slides (Ibidi) at a density
of 1.5 × 104 cells/well for live imaging, onto 24-well plates containing glass cov-
erslips at a density of 1.0 × 105 cells/well, onto 96-well glass bottom plates (Greiner)
or onto 96-well plates (Eppendorf) at a density of 8.0 × 104 cells/well 24 h before
transfection. Cells were then transfected with one, two or three expression plasmids
using X-tremeGENE 9 DNA transfection reagent (Roche) for 16–48 h, according to
the manufacturer’s instructions. A list of the plasmids and primers used in this
study is provided in Supplementary Table 1. For siRNA knock-down experiments,
cells were seeded onto 96-well plates at a density of 9.0 × 104 cells/well and on the
following day transfected with 3 pmol (25 nM) Stealth RNAiTM siRNAs (Thermo
Fisher Scientific) using Lipofectamine RNAiMax (a list of the siRNAs used in this
study is shown in Supplementary Table 2). After 8 h, cells were incubated with
IFNγ for an additional 16 h and experiments were then performed.
Infection assays and transfection of cells with LPS. When indicated, cells were
primed with 10 ng/mL human IFNγ (Peprotech) for 16 hours. Overnight Salmonella
cultures were sub-cultured 1/50 and grown until late exponential/early stationary
phase (OD600= 1.5–1.8). Overnight Shigella or Listeria cultures were sub-cultured
1/100 and grown until mid-exponential phase (OD600= 0.5–0.7). Before infection,
bacteria were collected by centrifugation, gently washed and resuspended in
DMEM. Salmonella was added to HeLa cells in 96-well plates (approximately 50,000
cells per well) at a multiplicity of infection (MOI) of 50 and incubated for 30min at
37 °C. For infection with Shigella or Listeria, bacteria were added to cells at a MOI of
20 and incubated for 30min at 37 °C. Non-internalized bacteria were removed by
three washes with warm DMEM and cells were incubated with DMEM containing
100 µg/mL gentamicin for 1 h to kill extracellular bacteria. Medium was then
changed to DMEM containing 10 µg/mL gentamicin and 10% FCS for the remained
of the experiment. At the desired time points p.i., cells were either processed for
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LDH release, enumeration of intracellular bacteria or fixed for immunofluorescence
assays. To enumerate intracellular bacteria, infected cells were gently washed with
PBS and lysed with water containing 0.2% Triton X-100. Bacteria were then serially
diluted and plated onto LB agar. To quantify the percentage of cytosolic Salmonella
in the total population, we used a CHQ resistance assay. Briefly, infected cells were
incubated with 200 µg/mL CHQ (Sigma-Aldrich) and gentamicin for 1 h (CHQ-
resistant bacteria) or with gentamicin only (total bacteria). Cells were washed, lysed
and bacteria were plated as described above. The percentage of cytosolic bacteria
was calculated by the ratio of (CHQ+ gentamicinresistant/gentamicinresistant). U937
and THP-1 cells were seeded and differentiated with 100 ng/mL PMA for 48 h,
followed by a 24 h resting period.
Transfection of cells with smooth LPS from E. coli O111:B4 (Invivogen) or
Salmonella (Sigma, L6143) was done at a concentration of 2.5 µg/50,000 cells, or
2.5 µg/80,000 cells (for THP-1 or U937), using Lipofectamine 2000 (Invitrogen).
Briefly, LPS was diluted in Opti-MEM and incubated with Lipofectamine 2000
(1.0 µl/50,000 cells) for 20 min at room temperature. 75 µl of Opti-MEM was added
to cells on 96-well plates and then 75 µl of LPS mixture was added on top. Plates
were centrifuged for 5 min at 211 × g and then incubated at 37 °C for the indicated
time points. For electroporation of HeLa or HBEC3-KT cells, the Neon
Transfection System (Life Technologies) was used. Briefly, naive or IFNγ-primed
cells were harvested, resuspended in resuspension buffer T and electroporated with
LPS from E. coli O111:B4 at a concentration of 300 ng/50,0000 cells, using
electrolytic buffer E and 1 pulse of 1300 V for 20 ms. Cells were then added to
200 µl pre-warmed Opti-MEM in a 96-well plate, centrifuged for 5 min at 211 × g
and then incubated at 37 °C. Mock electroporation and non-electroporated cells
were used as controls.
Microscopy, time-lapse imaging, and image analysis. Infected cells were washed
once with PBS and fixed in 4% PFA for 20min. Cells were then washed three times,
permeabilized with 0.05% saponin and blocked with 1% BSA. Coverslips were
incubated with antibodies when indicated and with Hoechst (1:1000) in PBS, and
then mounted in ProLong Gold Antifade (Life Technologies) for confocal micro-
scopy. Samples were imaged with a Zeiss LSM800 confocal laser scanning microscope
using a 63×/1.4 NA oil objective, by acquiring Z-stacks of 300 nm step size. For live
imaging, infection assays were performed in EM buffer (120mM NaCl, 7 mM KCl,
1.8mM CaCl2, 0.8 mM MgCl2, 5 mM glucose, 25 mM HEPES, pH 7.3). Cells were
infected for 10min as previously described, extracellular bacteria were removed by
washing with warm EM buffer, and time-lapse microscopy of living cells was per-
formed at 37 °C using a motorized xyz stage with autofocus. Super-resolution was
performed using the Zeiss LSM800 Airyscan super-resolution system using the same
objective and super-resolution images were calculated using the Zeiss ZEN software.
Data were further analyzed and processed using FiJi software, and all fluorescence
derived images shown here correspond to maximum 3D projections.
LDH release, PI uptake, IL-18 release, and western blotting. Cell death was
quantified by measuring LDH release to the supernatant, using the LDH cytotoxicity
detection kit (Takara, Clontech). To normalize for spontaneous cell lysis, the per-
centage of cell death was calculated as follows: (LDHsample – LDHnegative control)/
(LDHpositive control – LDHnegative control) × 100. PI influx measurement was performed
as previously described46. The levels of IL-18 were measured by ELISA (R&D
Sytems), according to the manufacturer’s instructions. For western blotting analysis,
cell lysates were prepared and supernatants were precipitated. Mouse anti-caspase-4
4B9 (ADI-AAM-114-E, Enzo Life Sciences, 1:750), rabbit anti-GSDMD (ab210070,
abcam, 1:1000), rabbit anti-GBP1 (ab121039, abcam, 1:1000), mouse anti-GAPDH
(AM4300, Thermo Scientific, 1:1000), mouse anti-V5 (R960-25, Thermo Scientific,
1:2000), mouse anti-GFP (632381, Clonetech, clone JL-8, 1:5000), mouse anti-HA
(ENZ-ABS-118-0200, Enzo Life Sciences, 1:2000), mouse anti-tubulin (ab40742,
Abcam, 1:2000) were used and detected with horseradish peroxidase-conjugated
secondary antibodies (1:5000, Southern Biotech).
Active caspase pull-down. HeLa cells were seeded onto 6-well plates and primed
for 16 h with 10 ng/mL human IFNγ. Approximately 3 × 106 cells were then treated
with 10 µM of biotin-VAD-fmk and transfected with 20 µg of E. coli LPS for 3
hours. Cells were lysed and incubated overnight with 20 µl of pre-washed strep-
tavidin magnetic beads (Thermo Scientific). The beads were washed as described
elsewhere47 and streptavidin-bound and left-over fractions (unbound) were ana-
lyzed on a 12% acrylamide gel and blotted against caspase-4.
Streptavidin pull-down assays. Approximately 2 × 106 cells were collected and
lysed in pull-down buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA,
1% NP40, 0.05% Na-deoxycolate and complete protease inhibitors). 700 µg of
protein (as determined by BCA assay (Thermo Scientific) from the total cell lysate
was incubated with 2 µg biotinylated LPS or with biotinylated Pam3CSK4 (Invi-
vogen) at room temperature for two hours with rocking. After incubation, 20 µl of
pre-washed streptavidin magnetic beads (Thermo Scientific) were added and
incubated for 1 h at room temperature with constant rocking. The beads were
washed three times in PBS with 0.05% Tween-20 and once with PBS and the
precipitates were eluted in equal volumes of SDS-PAGE reducing sample buffer
followed by western blotting analysis. 5% the of initial cell lysate (input) and equal
volumes of pull-down were analyzed. For GFP-GBP pulldown assay, cells were
lysed at a concentration of 20 × 106 cells/mL of lysis buffer (50 mM Tris pH 7.4,
150 mM NaCl, 10 mM MgCl2, 5 mM GTP, 300 μM AlF, 100 μg/mL digitonin
(Sigma) and allowed to lyse on ice for 15 min. The cells were then spun 15 min at
6000 × g, 4 °C. The soluble extract was then incubated with 2 µg LPS/million cells
equivalent and incubated at RT for 2 h with rotation. After incubation, streptavidin
magnetic beads were added to the mix and incubated for an additional hour with
rotation. The beads were than washed three times (30 min wash) with lysis buffer.
The beads where than resuspended in reducing western blot loading buffer before
being analyzed by immunoblotting.
Quantitative PCR (qPCR). Total mRNA was extracted from HeLa cells using the
RNeasy Mini kit (Qiagen) and up to 400 ng were reversed transcribed into cDNA
using the Verso cDNA Synthesis kit (Thermo Fisher Scientific). Gene expression
levels were quantified by qPCR using a LightCycler 480 (Roche) and LightCycler
480 SYBR Green I Master (Roche), according to standard protocols, by normal-
izing each sample to the respective levels of the housekeeping mRNA HPRT. The
list of primers used for qPCR is shown in Supplementary Table 3.
Purification of recombinant proteins. Full-length human GBP1 was cloned in
pET-28a to generate an N-terminally His-tagged hGBP1 construct. pET-28a-
hGBP1 was transformed into CleanColi BL21 (Lucigen), and the bacteria were
grown in 2xYT medium until an OD600 of 0.5-0.7. Protein expression was then
induced at 30 °C for 5 h with 0.2 mM IPTG. The bacterial pellet was resuspended in
resuspension buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% Tween 20) and frozen
at −80 °C until purification. For most assay, protein was freshly purified on a Ni-
NTA affinity column using standard protocols48. Protein yield was quantified using
Beer-Lambert law. After purification on a Ni-NTA columns, GBP1 was further
purified on a size exclusion chromatography column (Superdex 200 10/30 GL, GE
Healthcare) in running buffer (50 mM Tris pH 7.4, 150 mM NaCl) and con-
centrated using Amicon Ultra4 10 kDa (Millipore).
Size exclusion chromatography of GBP1 and LPS. Freshly purified GBP1 (1 µM)
was incubated on ice alone or with a two-fold molar excess of LPS or LPS-
derivatives for 5 h. Ultrapure O11:B4 E.coli LPS (Invivogen), Salmonella Typhi-
murium Smooth LPS (Enzo Life Science), Rhodobacter sphaeroides ultrapure LPS
(Invivogen), E. coli F585 diphosphoryl Lipid A (Sigma-Aldrich), Salmonella min-
nesota 595 Lipid A (Invivogen), synthetic monophosphorylated Lipid A (Invivo-
gen), E.coli EH100 LPS Ra mutant (Sigma-Aldrich), E.coli J5 LPS Rc mutant
(Sigma-Aldrich), E.coli F583 LPS Rd mutant (Sigma-Aldrich), E. coli R515 LPS Re
mutant (Enzo Life Science) was used. After incubation, GBP1 alone or GBP-LPS
incubations were injected into a Superdex 200 10/30 GL column and run in
running buffer for 1 column volume. Individual fractions (500 µL), were collected,
precipitated with methanol and chloroform49, separated on a 12% acrylamide gel
and analyzed by immunoblotting using an antibody against His6 tag. Experimental
molecular weights of the peaks were approximated using a gel filtration standard
(1511901; Bio-Rad). Where indicated, LPS was pre-incubated with 5 mM CaCl2 for
5 min on ice before being added to GBP1, as indicated above, or LPS was pre-
incubated with polymyxin B (10 µg/mL) for 5 min at room temperature.
Surface plasmon resonance (SPR). SPR measurements were performed on the
Biacore T200 (GE Healthcare Life Sciences). GPB1 was immobilized on a
CM5 sensor chip (GE Healthcare) using the amine coupling procedure (immobi-
lization response was 310 RU or 0.31 ng/mm2). Then it was equilibrated in PBS
buffer (pH 7.2; Gibco, Life Sciences), followed by the injection of the increasing
concentrations of LPS (47, 94, 188, 375, 750, 1500 nM) into the flow channels. In the
reverse experiment, when immobilizing LPS on the CM5 sensor chip, increasing
concentrations of GBP1 (21.5, 43, 86, 172, 343, 688, 1375, 2750 nM) were used. Data
were analyzed using BiacoreT200 Evaluation software 3.0. An equilibrium analysis
was done using Langmuir isotherm fit with one equilibrium dissociation constant
(KD). The best fit for the Kinetic curves was obtained with the two-state-reaction
model that assume a possible structural re-arrangement after the initial binding.
Microscale thermophoresis (MST). MTS was performed on 50 nM of FITC-
labeled E. coli LPS (Sigma-Aldrich) using freshly purified hGBP1 expressed
recombinantly (as described above) or BSA as a control. Serial dilutions of GBP1 or
BSA were analyzed in assay buffer (50 mM Tris pH 7.4, 150 mM NaCl). Experi-
ment was performed on a Nanotemper Monolith NT.115 microscale electro-
phoresis instrument with medium MST power. Data were fitted to a 1:1 binding
model with the MO.Affinity Analysis software.
GTPase activity assay. GTPase activity assay was performed using the GTPase-
GloTM kit (Promega) according to the manufacturer use. Recombinant human
GBP1 (500 nM) was incubated with 5 µM LPS in GEF buffer (Promega) for 30 min
at room temperature before assessing GTP hydrolysis. Luminescence values were
normalized to a no-GBP1 control.
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Data analysis. Data analysis was performed using the following software: Gen5,
GraphPad Prism v8 and Microsoft Excel. Statistical significances are referred as *,
** or *** for P-values <0.05, <0.01 or <0.001, respectively. For comparison of two
groups, a two-tailed t-test was used, whereas for comparison of three or more
groups P-values were determined using the two-way analysis of variance for
multiple comparisons.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data corresponding to Figs. 1h–i; 2a, d, e; 6a, f and Supplementary Figs. 1g;
2c, f–h; 3q; 5b; 10d, f; 11e; 14b are provided as Source Data files. All other relevant data
are available from the corresponding author upon reasonable request. Source data are
provided with this paper.
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